Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2019-03-27 | 2019-06-21 | 79589 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-02-16 | 2023-04-04 | 185042 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-04-06 | 2023-07-13 | 188982 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-05-26 | 2023-07-13 | 193230 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2023-06-09 | 2023-07-13 | 194564 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2025-02-06 | 2025-03-13 | 249746 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2025-05-01 | 2025-05-01 | 256322 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2019-10-16 | 2019-11-25 | 96650 |
| APO-MEMANTINE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 381 |
| APO-MEMANTINE | 10MG | TABLET | Resolved | 2017-06-28 | 2020-06-03 | 14191 |
| APO-MEMANTINE | 10MG | TABLET | Resolved | 2022-07-29 | 2022-10-14 | 165723 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-27 | 2022-06-03 | 161442 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-12-05 | 2021-05-03 | 100281 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-12-05 | 2023-07-04 | 100284 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-06-06 | 2024-07-26 | 229761 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-18 | 2019-01-28 | 69915 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-08-13 | 2023-10-15 | 201719 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-01 | 2024-01-26 | 212362 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-19 | 2024-06-14 | 225770 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-05-14 | 2021-06-14 | 139413 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |